Fabiënne van Puijfelik

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Cell Cycle Arrest

Cerebrospinal Fluid

Microbial Community

Top Venues

Brain communications

European journal of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Fabiënne van Puijfelik, Katelijn M Blok, Romy A M Klein Kranenbarg, Jasper Rip, Janet de Beukelaar, Annet F Wierenga-Wolf, Beatrijs Wokke, Marvin M van Luijn, Joost J F M Smolders
Ocrelizumab associates with reduced cerebrospinal fluid B and CD20 dim CD4 + T cells in primary progressive multiple sclerosis. Brain communications 6 (1) (2024)
Fabiënne van Puijfelik, Katelijn M Blok, Romy A M Klein Kranenbarg, Jasper Rip, Janet de Beukelaar, Annet F Wierenga-Wolf, Beatrijs Wokke, Marvin M van Luijn, Joost J F M Smolders
Ocrelizumab associates with reduced cerebrospinal fluid B and CD20 dim CD4 + T cells in primary progressive multiple sclerosis. Brain communications 6 (1) (2024)
Cindy Hoeks, Fabiënne van Puijfelik, Steven C Koetzier, Jasper Rip, Cato E A Corsten, Annet F Wierenga-Wolf, Marie-José Melief, Piet Stinissen, Joost J F M Smolders, Niels Hellings, Bieke Broux, Marvin M van Luijn
Differential Runx3, Eomes, and T-bet expression subdivides MS-associated CD4 + T cells with brain-homing capacity. European journal of immunology (2023)